17-Hydroxysteroid dehydrogenases

Preferred Label : 17-Hydroxysteroid dehydrogenases;

MeSH definition : A class of enzymes that catalyzes the oxidation of 17-hydroxysteroids to 17-ketosteroids. EC 1.1.-.;

MeSH synonym : 17 ketosteroid reductases; reductases, 17-ketosteroid; dehydrogenases, 17-hydroxysteroid; 17-ketosteroid reductases; 17 hydroxysteroid dehydrogenases;

MeSH hyponym : 17 beta-Hydroxysteroid dehydrogenases; testosterone dehydrogenases; Dehydrogenases, Testosterone; 17 beta Hydroxysteroid Dehydrogenases; Dehydrogenases, 17 beta-Hydroxysteroid;

Registry Number MeSH : EC 1.1.-;

Is substance : O;

Details

Origin ID

D015067;

UMLS CUI

C0000165;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- 3beta-hydroxysteroid dehydrogenase (substance) [SNOMED CT concept]
- Estradiol 17-Beta-Dehydrogenase 2 [NCIt concept]
Indexing information
- 1,2,7,8,9,10,11,13-octahydro-4-(3-hydroxyphenylthio)-13-oxo-(1)benzothieno-(2',3'-4,5)pyrimido(1,2-a)azepine-3-carboxaldehyde [MeSH Supplementary Concept]
- 1-acetyl-5-(2-(4-chlorophenoxy)phenylamino)-2,3,4,5-tetrahydrobenzo(b)azepine [MeSH Supplementary Concept]
- 2,5-diphenyl-4-benzoquinone [MeSH Supplementary Concept]
- 2-ethyl-16-((3-pyridylmethylamino)carbonylmethyl)estrone [MeSH Supplementary Concept]
- 2-fluoro-4-(5-(3-hydroxyphenyl)-2-thienyl)phenol [MeSH Supplementary Concept]
- 2-methyl-1-(1-((5-methyl-1H-indol-2-yl)carbonyl)piperidin-4-yl)propan-2-ol [MeSH Supplementary Concept]
- 3-((N-adamantylmethyl-N-butanoyl)aminomethyl)-3-hydroxyandrostan-17-one [MeSH Supplementary Concept]
- 3-(3',17'-dihydroxyestra-1',3',5'(10')-trien-16'-methyl)benzamide [MeSH Supplementary Concept]
- 3-acetyl-7-(4-hydroxyphenyl)-2H-chromen-2-one [MeSH Supplementary Concept]
- 3-cyclohexylethylandrosterone [MeSH Supplementary Concept]
- 3-hexylandrosterone [MeSH Supplementary Concept]
- 3-phenylethylandrosterone [MeSH Supplementary Concept]
- 5'-O-(11-androst-4'-en-3',17'-dioxo-16'-yl)dodecanoyl-2'-O-phosphate-adenosine [MeSH Supplementary Concept]
- 5'-O-(11-androst-4'-en-3',17'-dioxo-16'-yl)dodecanoyladenosine [MeSH Supplementary Concept]
- 6-(4-hydroxy-3-(trifluoromethyl)phenyl)-1-naphthol [MeSH Supplementary Concept]
- EM-1745 [MeSH Supplementary Concept]
- N-(pyridin-3-ylmethyl)estrone-16-methylcarboxamide [MeSH Supplementary Concept]
- N-butyl-N-methyl-11-(3'-hydroxy-21'-17'-carbolactone-19'-nor-17' -pregna-1',3',5'(10')-trien-7'-yl)-undecanamide [MeSH Supplementary Concept]
- N-butyl-N-methyl-7-(3',17'beta-dihydroxy-1',3',5'(10')-estratriene-6'beta-yl)-7-thiaheptanamide [MeSH Supplementary Concept]
- alpha-methylcinnamic acid [MeSH Supplementary Concept]
- spiro(3'-(3'-N-morpholino-2'-(3'''-cyclopentylpropionyloxy)propyl)-2'-oxooxazolidin-5'-yl)androstan-17-one [MeSH Supplementary Concept]
Record concept(s)
- 17 beta-Hydroxysteroid dehydrogenases [MeSH concept]
- 17-Hydroxysteroid dehydrogenases [MeSH concept]
- testosterone dehydrogenases [MeSH concept]
Related MeSH Supplementary Concept(s)
- 17 beta-hydroxysteroid dehydrogenase type 10, drosophila [MeSH Supplementary Concept]
- 17-Hydroxysteroid dehydrogenase deficiency [MeSH Supplementary Concept]
- 17beta-hydroxysteroid dehydrogenase type 11, mouse [MeSH Supplementary Concept]
- 17beta-hydroxysteroid dehydrogenase type 13, mouse [MeSH Supplementary Concept]
- 17beta-hydroxysteroid dehydrogenase type 3 [MeSH Supplementary Concept]
- 3 (or 17)-beta-hydroxysteroid dehydrogenase [MeSH Supplementary Concept]
- 3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+)) [MeSH Supplementary Concept]
- AKR1C3 protein, rat [MeSH Supplementary Concept]
- DHRS11 protein, human [MeSH Supplementary Concept]
- HSD17B11 protein, human [MeSH Supplementary Concept]
- HSD17B12 protein, mouse [MeSH Supplementary Concept]
- HSD17B13 protein, human [MeSH Supplementary Concept]
- HSD17B14 protein, human [MeSH Supplementary Concept]
- Hsd17b2 protein, rat [MeSH Supplementary Concept]
- Hsd17b4 protein, rat [MeSH Supplementary Concept]
- PRAP protein, mouse [MeSH Supplementary Concept]
- androstenedione 17-alpha-oxidoreductase [MeSH Supplementary Concept]
- hydroxysteroid (17-beta) dehydrogenase 1, mouse [MeSH Supplementary Concept]
- polycystic ovarian disease due to 17-Ketosteroid reductase deficiency [MeSH Supplementary Concept]
- testosterone 17 beta-dehydrogenase (NADP+) [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients